Skip to main content
Clinical Trials/ISRCTN23657907
ISRCTN23657907
Active, Not Recruiting
N/A

A multi-centre randomised controlled trial of the clinical and cost-effectiveness of pre-hospital whole blood administration versus standard care for traumatic haemorrhage

HS Blood and Transplant0 sites848 target enrollmentDecember 7, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Traumatic haemorrhage
Sponsor
HS Blood and Transplant
Enrollment
848
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37964393/ RCT protocol (added 16/11/2023) 2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38316586/ Implementation study protocol (added 06/02/2024)

Registry
who.int
Start Date
December 7, 2022
End Date
June 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HS Blood and Transplant

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient (of any age) who has suffered a traumatic injury
  • 2\. Attended by a participating Air Ambulance Service (AAS) clinical team
  • 3\. Requires pre\-hospital blood transfusion to treat major traumatic haemorrhage

Exclusion Criteria

  • 1\. No intravenous or intraosseous access
  • 2\. Knowledge that the patient will object to being given blood transfusion for any reasons
  • 3\. Blood already administered on\-scene, prior to the arrival of the participating Air Ambulance team

Outcomes

Primary Outcomes

Not specified

Similar Trials